236 related articles for article (PubMed ID: 16145167)
1. Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe.
Marqué S; Poirel L; Héritier C; Brisse S; Blasco MD; Filip R; Coman G; Naas T; Nordmann P
J Clin Microbiol; 2005 Sep; 43(9):4885-8. PubMed ID: 16145167
[TBL] [Abstract][Full Text] [Related]
2. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp.
Poirel L; Figueiredo S; Cattoir V; Carattoli A; Nordmann P
Antimicrob Agents Chemother; 2008 Apr; 52(4):1252-6. PubMed ID: 18195058
[TBL] [Abstract][Full Text] [Related]
3. Production of a plasmid-encoded OXA-72 β-lactamase associated with resistance to carbapenems in a clinical isolate Acinetobacter junii.
Fernández-Cuenca F; Rodríguez-Martínez JM; Gómez-Sánchez MA; de Alba PD; Infante-Martínez V; Pascual A
Int J Antimicrob Agents; 2012 Jan; 39(1):93-4. PubMed ID: 21982835
[No Abstract] [Full Text] [Related]
4. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Poirel L; Nordmann P
Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
[TBL] [Abstract][Full Text] [Related]
5. First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy.
Bertini A; Giordano A; Varesi P; Villa L; Mancini C; Carattoli A
Antimicrob Agents Chemother; 2006 Jun; 50(6):2268-9. PubMed ID: 16723603
[No Abstract] [Full Text] [Related]
6. Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter phenon 6/ct13TU clinical isolate.
Marti S; Sánchez-Céspedes J; Blasco MD; Espinal P; Ruiz M; Alba V; Vila J
Diagn Microbiol Infect Dis; 2008 Aug; 61(4):468-70. PubMed ID: 18485655
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil.
Mostachio AK; Levin AS; Rizek C; Rossi F; Zerbini J; Costa SF
Int J Antimicrob Agents; 2012 May; 39(5):396-401. PubMed ID: 22455794
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Wang H; Guo P; Sun H; Wang H; Yang Q; Chen M; Xu Y; Zhu Y
Antimicrob Agents Chemother; 2007 Nov; 51(11):4022-8. PubMed ID: 17846127
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres.
Vahaboglu H; Budak F; Kasap M; Gacar G; Torol S; Karadenizli A; Kolayli F; Eroglu C
J Antimicrob Chemother; 2006 Sep; 58(3):537-42. PubMed ID: 16816400
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Marti S; Sánchez-Céspedes J; Blasco MD; Ruiz M; Espinal P; Alba V; Fernández-Cuenca F; Pascual A; Vila J
Antimicrob Agents Chemother; 2008 Aug; 52(8):2955-8. PubMed ID: 18505859
[TBL] [Abstract][Full Text] [Related]
11. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.
Héritier C; Dubouix A; Poirel L; Marty N; Nordmann P
J Antimicrob Chemother; 2005 Jan; 55(1):115-8. PubMed ID: 15590718
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of
Lasarte-Monterrubio C; Guijarro-Sánchez P; Bellés A; Vázquez-Ucha JC; Arca-Suárez J; Fernández-Lozano C; Bou G; Beceiro A;
Microbiol Spectr; 2022 Feb; 10(1):e0273421. PubMed ID: 35138195
[TBL] [Abstract][Full Text] [Related]
13. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
Mendes RE; Bell JM; Turnidge JD; Castanheira M; Jones RN
J Antimicrob Chemother; 2009 Jan; 63(1):55-9. PubMed ID: 18957398
[TBL] [Abstract][Full Text] [Related]
14. How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital.
Lu PL; Huang LY; Lian ST; Chang K; Lin CL; Hwang IJ; Chiang WG; Chen YH; Lin SF; Siu LK
Int J Antimicrob Agents; 2008 May; 31(5):463-6. PubMed ID: 18359613
[TBL] [Abstract][Full Text] [Related]
15. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
Amudhan SM; Sekar U; Arunagiri K; Sekar B
Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108
[TBL] [Abstract][Full Text] [Related]
16. Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain.
Mugnier PD; Bindayna KM; Poirel L; Nordmann P
J Antimicrob Chemother; 2009 May; 63(5):1071-3. PubMed ID: 19252183
[No Abstract] [Full Text] [Related]
17. OXA-58 and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from Australia.
Peleg AY; Franklin C; Walters LJ; Bell JM; Spelman DW
Antimicrob Agents Chemother; 2006 Jan; 50(1):399-400. PubMed ID: 16377723
[No Abstract] [Full Text] [Related]
18. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India.
Tiwari V; Kapil A; Moganty RR
Microb Pathog; 2012 Aug; 53(2):81-6. PubMed ID: 22610043
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand.
Niumsup PR; Boonkerd N; Tansawai U; Tiloklurs M
Jpn J Infect Dis; 2009 Mar; 62(2):152-4. PubMed ID: 19305059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
